Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Also, patients with DS in this study had relatively high rates of Vitamin D deficiency (38.9%), constipation (22.2%), and gastroesophageal reflux disease (18.5%), though their rates were lower than those with other medical conditions.

Source: Key question #3: Impact of diagnoses. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Scoping review.

Scoping review

Maps the extent and characteristics of research on a topic.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Disparities and outcomes of patients living with Down Syndrome undergoing healthcare transitions from pediatric to adult care: A scoping review

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Disparities and outcomes of patients living with Down Syndrome undergoing healthcare transitions from pediatric to adult care: A scoping review

Scoping review · American Journal of Medical Genetics. Part a · 2022

Original publication title

Disparities and outcomes of patients living with Down Syndrome undergoing healthcare transitions from pediatric to adult care: A scoping review

Karan Varshney; Rosemary Iriowen; Kayla Morrell; Preshon Pillay; Alexander Fossi; Mary M. Stephens

© 2022 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Abstract

Down Syndrome (DS) is one of the most common chromosomal disorders worldwide, and people with DS experience more co‐morbidities and have poorer health outcomes compared to the general population. An area that is not well understood is how patients with DS transition from pediatric to adult care, as well as the details, barriers, and difficulties of these transitions for patients. Hence, we aimed to provide a scoping review of the literature in PubMed, Scopus, and CINAHL on the topic of healthcare transitions (HCTs) for patients with DS.

Findings suggest patients with DS who continued receiving care as an adult from a pediatric care provider tended to experience co‐morbidities and other adverse health issues at higher rates than those who entirely switch to an adult‐care team. Patients with DS were unable to undergo transition due to multiple barriers, such as low income, limited/public insurance, gender, and race. We propose potential steps for transition, which focus on ensuring early planning, communicating better, coordinating services, assessing decision‐making capacity, and providing ongoing social and financial support.

Future research must further identify and address barriers to HCTs for people with DS.

Authors’ abstract

Abstract

Down Syndrome (DS) is one of the most common chromosomal disorders worldwide, and people with DS experience more co‐morbidities and have poorer health outcomes compared to the general population. An area that is not well understood is how patients with DS transition from pediatric to adult care, as well as the details, barriers, and difficulties of these transitions for patients. Hence, we aimed to provide a scoping review of the literature in PubMed, Scopus, and CINAHL on the topic of healthcare transitions (HCTs) for patients with DS.

Findings suggest patients with DS who continued receiving care as an adult from a pediatric care provider tended to experience co‐morbidities and other adverse health issues at higher rates than those who entirely switch to an adult‐care team. Patients with DS were unable to undergo transition due to multiple barriers, such as low income, limited/public insurance, gender, and race. We propose potential steps for transition, which focus on ensuring early planning, communicating better, coordinating services, assessing decision‐making capacity, and providing ongoing social and financial support.

Future research must further identify and address barriers to HCTs for people with DS.

Publication and source details

Original title: Disparities and outcomes of patients living with Down Syndrome undergoing healthcare transitions from pediatric to adult care: A scoping review

Karan Varshney; Rosemary Iriowen; Kayla Morrell; Preshon Pillay; Alexander Fossi; Mary M. Stephens

American Journal of Medical Genetics. Part a · 2022

* Correspondence
Karan Varshney, Deakin University, School of Medicine, 75 Pigdons, Waurn Ponds, Geelong, VIC 3216, Australia.
Email: karan.varshney@students.jefferson.edu
© 2022 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T08:54:19.534944+00:00

DOI: 10.1002/ajmg.a.62854 · PMC9545419